Application | Comment | Organism |
---|---|---|
medicine | excision of RCE1 from skin carcinoma cell line retards the growth of cells significantly, and this effect was exaggerated by co-treatment with farnesyl-transferase inhibitor | Mus musculus |
Protein Variants | Comment | Organism |
---|---|---|
additional information | RCE1 deficient mice generated, loss of the enzyme results in late embryonic lethality | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
beta-(2-naphthyl)-Ala-CH2Cl | affinity labeling agent of the enzyme | Bos taurus | |
additional information | not inhibited by chyostatin, DTT, E-64, 1,10-phenanthroline and PMSF, Tos-Lys-CH2Cl | Bos taurus | |
N-Boc-S-farnesyl-L-cys-CH2Cl | - |
Bos taurus | |
N-Boc-S-farnesyl-L-cysteine aldehyde | potent competetive inhibitor | Bos taurus | |
p-chloromercuribenzoate | inactivates the partially purified enzyme, with 0.005 mM substantial inhibition | Bos taurus | |
pseudo peptide R (CH2-NH) | - |
Bos taurus | |
Tos-Phe-CH2Cl | affinity labeling agent of the enzyme | Bos taurus |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0057 | - |
N-acetyl-S-farnesyl-L-cysteinyl-L-valyl-L-isoleucyl-L-serine | - |
Bos taurus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | - |
Homo sapiens | 16020 | - |
microsome | - |
Bos taurus | - |
- |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Bos taurus | - |
- |
- |
Homo sapiens | - |
- |
- |
Mus musculus | - |
- |
- |
Saccharomyces cerevisiae | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
carcinoma cell line | from skin | Mus musculus | - |
liver | - |
Bos taurus | - |
MEF cell | - |
Mus musculus | - |
additional information | Sf9 cell | Homo sapiens | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.00000251 | - |
with N-acetyl-S-farnesyl-Cys+Val-Ile-Ser as substrate | Bos taurus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
a-factor-CaaX + H2O | CaaX proteolysis of all three forms of Ras and other CaaX proteins is absent in RCE1 deficient mice, RCE1 is required for correct localization of these proteins | Mus musculus | a-factor-C + aaX | - |
? | |
N-acetyl-S-farnesyl-Cys-Val-Ile-Ser + H2O | - |
Bos taurus | N-acetyl-S-farnesyl-Cys + Val-Ile-Ser | - |
? | |
N-Boc-S-farnesyl-L-Cys-Val-Ile-Met + H2O | - |
Bos taurus | N-Boc-S-farnesyl-L-Cys + Val-Ile-Met | - |
? |
Synonyms | Comment | Organism |
---|---|---|
isoprenylated protein peptidase | - |
Mus musculus |
isoprenylated protein peptidase | - |
Homo sapiens |
isoprenylated protein peptidase | - |
Saccharomyces cerevisiae |
isoprenylated protein peptidase | - |
Bos taurus |
RCE1 | - |
Mus musculus |
RCE1 | - |
Homo sapiens |
RCE1 | - |
Saccharomyces cerevisiae |
RCE1 | - |
Bos taurus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7 | - |
- |
Bos taurus |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000085 | - |
pseudo peptide R (CH2-NH) | - |
Bos taurus | |
0.002 | - |
N-Boc-S-farnesyl-L-cysteine aldehyde | - |
Bos taurus | |
0.03 | - |
N-Boc-S-farnesyl-L-cys-CH2Cl | - |
Bos taurus |